Insulet
PODD
#1479
Rank
HK$112.35 B
Marketcap
HK$1,596
Share price
-1.65%
Change (1 day)
-22.09%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2025 (TTM): HK$3.10 Billion

According to Insulet's latest financial reports the company's current earnings are HK$2.70 Billion. , an increase over its 2024 earnings that were of HK$2.68 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2025

Annual earnings

Year Earnings Change
2025 HK$3.12 B16.27%
2024 HK$2.68 B36.76%
2023 HK$1.96 B481.9%
2022 HK$0.33 B-45.24%
2021 HK$0.61 B43.35%
2020 HK$0.43 B18.51%
2019 HK$0.36 B41.16%
2018 HK$0.25 B-711.95%
2017 -HK$42.04 Million-56.85%
2016 -HK$97.43 Million-79.31%
2015 -HK$0.48 Billion63.85%
2014 -HK$0.29 Billion31.04%
2013 -HK$0.22 Billion-21.96%
2012 -HK$0.29 Billion
2010 -HK$0.27 Billion-42.38%
2009 -HK$0.47 Billion-33.56%
2008 -HK$0.71 Billion65.93%
2007 -HK$0.43 Billion209.75%
2006 -HK$0.14 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
HK$262.97 B 8,313.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$66.35 B 2,022.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
HK$49.18 B 1,473.72%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
HK$201.67 B 6,352.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-HK$1.61 Billion-151.39%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
HK$0.76 B-75.50%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
HK$8.67 B 177.51%๐Ÿ‡บ๐Ÿ‡ธ USA